Christopher George Bazewicz

Christopher Bazewicz practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Christopher Bazewicz's NPI, 1942763370, was assigned on April 11, 2019. Christopher Bazewicz graduated from Pennsylvania State University College of Medicine in 2019. Christopher Bazewicz holds Pennsylvania license MD481599.

Christopher Bazewicz's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Christopher Bazewicz's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Christopher Bazewicz is also affiliated with Lancaster General Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Christopher Bazewicz to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Bazewicz practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Christopher Bazewicz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Christopher Bazewicz is licensed in Pennsylvania.

CMS data shows 1,551 Medicare services from Christopher Bazewicz across 11 procedure codes in 2024, for 535 Medicare patients. Medicare paid $41,990 for them.

CMS counts 535 Medicare patients who saw Christopher Bazewicz in 2024. The largest group is 65 to 74, with 259 patients. 73% of them have high cholesterol, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Bazewicz's median patient age at 73, with 47% women.

In 2024, Christopher Bazewicz wrote 1,133 Medicare Part D claims for 280 patients. 74% of them were for generic drugs. CMS names the drug for 983 of them, across 33 drugs with 11 or more claims each, at $1,694,592 in total drug cost. In 2023, CMS named 607 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Christopher Bazewicz for performance year 2024, reported as part of a group. Christopher Bazewicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 257 procedures of skin biopsy by Christopher Bazewicz, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Christopher Bazewicz, published from 2012 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Aldehyde Dehydrogenase, Nitriles and Phenylalanine. Christopher Bazewicz has published most often in Am J Dermatopathol. Christopher Bazewicz's most frequent co-authors are Matthew F. Helm, MD, Thomas N. Helm, MD and Galen Toye Foulke, MD.

CMS Open Payments shows 27 general payments to Christopher Bazewicz from 8 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 91% of the total. Kyowa Kirin, Inc. paid the most, $526.

Christopher Bazewicz graduated from Pennsylvania State University College of Medicine in 2019.